Somapacitan-beco
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Sogroya (generic: somapacitan-beco) is a prescription injection solution made by Novo Nordisk for subcutaneous use. It contains somapacitan at 3.3 mg/mL strength and was approved under BLA761156, with marketing starting in May 2023. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Somapacitan-beco
Access the FDA dataset for Somapacitan-beco — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025